BioUtah COVID-19 Life Sciences Survey
March 17, 2020
TIME SENSITIVE – PLEASE TAKE SURVEY
Dear Members of Utah’s Life Sciences Community,
BioUtah is taking a multi-pronged approach to support our life sciences companies, industry workforce, and communities during the COVID-19 pandemic, including:
- Working directly with the Utah State Coronavirus Task Force to identify products and resources needed in the state
- Indentifing funding sources from state and federal governments to support emergency countermeasures and other responses
- Gaining a better understanding of how our companies are impacted and how BioUtah can provide assistance
We ask you to respond to a brief survey by Friday, March 20.
Recent News
- RefloDx Closes $2 Million Seed Round to Advance Noninvasive Testing for Chronic Throat and Voice Symptoms
- Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
- Ultragenyx sells second rare pediatric PRV in a week for $203M
- Co-Diagnostics’ Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
- Route 92 Medical Announces $100 Million Corporate Debt Facility
- Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
